Skip to content

Journal of Psychoactive Drugs

ISSN 0279-1072, 2159-9777

419 papers in the library · 13,118 citations · publishing 1976-2026

Papers

Sort Most recent Most cited

"Bath Salt" Use and Beliefs about Use among Electronic Dance Music Attendees.

Journal of Psychoactive Drugs 2018 Joseph J Palamar

Use of synthetic cathinones ("bath salts") has been associated with tens of thousands of emergency department visits. Few surveys, however, query use. Research on "bath salt" use is needed, especially in high-risk populations, to inform prevention and harm reduction efforts. A total of 933 adults (ages 18-40) were surveyed entering electronic dance music (EDM) parties in New York City in 2017....

DOI: 10.1080/02791072.2018.1517229 (opens in new tab) Full text (opens in new tab) MDMA Dance music New psychoactive substances Synthetic cathinones

What's in a Name? Correlates of Ecstasy Users Knowing or Agreeing that Molly is Ecstasy/MDMA.

Journal of Psychoactive Drugs September 22, 2017 Joseph J Palamar

Ecstasy (MDMA) has regained popularity in powder and crystalline form, known as Molly. However, it is unknown whether all Molly users are aware that Molly is ecstasy. A total of 1045 nightclub/festival-attending adults in New York City were surveyed about ecstasy/MDMA/Molly use in 2016. Users were asked if they agreed that "Molly is (or is supposed to be) ecstasy/MDMA." Of the 43.5% reporting...

Nourishing the Spirit: Exploratory Research on Ayahuasca Experiences along the Continuum of Recovery from Eating Disorders

Journal of Psychoactive Drugs September 12, 2017 Adele Lafrance, Anja Loizaga-Velder, Jenna Fletcher et al. 126 citations

Eating disorders (EDs) are serious health conditions that are among the most difficult to treat. Innovative treatments are needed and modalities from across cultures must be considered. Ayahuasca is a psychoactive plant-based tea originally used by Amazonian indigenous groups. A growing body of research points to its promise in the healing of various mental health issues. This study explored...

DOI: 10.1080/02791072.2017.1361559 (opens in new tab) Ayahuasca Thematic analysis Context archaeology Mental health +7

William Burroughs: Sailor of the Soul

Journal of Psychoactive Drugs August 10, 2017 Andrew J. Lees 4 citations

In 1953, William Seward Burroughs made several important and largely unrecognized discoveries relating to the composition and clinical pharmacological effects of the hallucinogenic plant potion known as yagé or ayahuasca. Illustrations of Burroughs' voucher sample of Psychotria viridis and his letter to the father of modern ethnobotany, Richard Evans Schultes, are published here for the very...

A Physician’s Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT)

Journal of Psychoactive Drugs August 8, 2017 Tanida Brown, Wanda Shao, Shehzad Ayub et al. 21 citations

N,N-dimethyltryptamine (DMT) is a psychoactive substance that has been gaining popularity in therapeutic and recreational use. This is a case of a physician who chronically took DMT augmented with phenelzine in an attempt to self-medicate refractory bipolar depression. His presentation of altered mental status, mania, and psychosis is examined in regards to his DMT use. This case discusses DMT,...

Placebo Effects of Edible Cannabis: Reported Intoxication Effects at a 30-Minute Delay

Journal of Psychoactive Drugs August 3, 2017 Mallory Loflin, Mitch Earleywine, Stacey Farmer et al. 7 citations

Previous research has demonstrated the ability of non-active smoked cannabis cigarettes to induce subjective effects of intoxication (i.e., placebo effect). No studies have been conduced to test whether edible forms of cannabis, which are associated with a significant delay in onset of effect, are able to induce a placebo effect. In the present study, 20 participants were told that they would...

Something New about Something Old: A 10-Year Follow-Up on Classical and New Psychoactive Tryptamines and Results of Analysis

Journal of Psychoactive Drugs June 1, 2017 Álvaro José Palma-Conesa, Mireia Ventura, Liliana Galindo et al. 65 citations

New psychoactive tryptamines may be a public health risk since they intend to mimic the hallucinogenic effects of regulated psychoactive drugs. Few studies describe uses and clinical effects of unregulated new psychoactive tryptamines. This study aims (1) to explore the presence of tryptamines classified as NPS among the substances delivered for analysis to a harm-reduction organization; (2) to...

DOI: 10.1080/02791072.2017.1320732 (opens in new tab) Tryptamines Hallucinogen Pharmacology

Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders

Journal of Psychoactive Drugs May 8, 2017 Kelan Thomas, Benjamin Malcolm, Dan Lastra 77 citations

Recent research suggests that functional connectivity changes may be involved in the pathophysiology of psychiatric disorders. Hyperconnectivity in the default mode network has been associated with psychopathology, but psychedelic serotonin agonists like psilocybin may profoundly disrupt these dysfunctional neural network circuits and provide a novel treatment for psychiatric disorders. We have...

Psychedelics, Personality and Political Perspectives.

Journal of Psychoactive Drugs April 26, 2017 Matthew M. Nour, Lisa Evans, Robin Carhart-Harris 230 citations

The psychedelic experience (including psychedelic-induced ego dissolution) can effect lasting change in a person's attitudes and beliefs. Here, we aimed to investigate the association between naturalistic psychedelic use and personality, political perspectives, and nature relatedness using an anonymous internet survey. Participants (N = 893) provided information about their naturalistic...

DOI: 10.1080/02791072.2017.1312643 (opens in new tab) Psychedelics Hallucinogens Entheogens Mind-altering drugs +11

Motivations for Using MDMA (Ecstasy/Molly) among African Americans: Implications for Prevention and Harm-Reduction Programs

Journal of Psychoactive Drugs April 13, 2017 Khary K. Rigg 33 citations

Despite the growing popularity of MDMA (ecstasy/molly) among African Americans, their motives for using the drug are still largely unknown. The purpose of this study was to identify and describe the most salient motivations for using MDMA among this understudied population. In-depth interviews (n = 15) were conducted with a sample of African American young adults in Southwest Florida between...

DOI: 10.1080/02791072.2017.1305518 (opens in new tab) MDMA Ecstasy Harm reduction Psychological intervention +1

Examination of the Phenomenology of the Ibogaine Treatment Experience: Role of Altered States of Consciousness and Psychedelic Experiences.

Journal of Psychoactive Drugs 2017 Annamarie Heink, Steve Katsikas, Tiffany Lange-Altman 35 citations

Psychedelic drugs have historically been used for ritualistic purposes and to help individuals gain insight. Ibogaine, a naturally occurring psychoactive substance, has been reported to have anti-addictive properties that aid in the treatment of substance use disorders. An online survey obtained retrospective data from individuals who used ibogaine in the past. Individuals who used ibogaine...

Beyond Ketamine and Phencyclidine: Analytically Confirmed Use of Multiple Novel Arylcyclohexylamines.

Journal of Psychoactive Drugs 2017 Stephen L Thornton, David Lisbon, Thomas Lin et al.

Methoxetamine and 3-methoxy-phencyclidine are novel arylcyclohexylamines whose use and clinical toxicity are poorly reported in the medical literature. We report a case of analytically confirmed use of both methoxetamine and 3-methoxy-phencyclidine. A 27-year-old male presented 10 hours after insufflating an Internet-obtained powder. He was hypertensive, tachycardic, and demonstrated...

DOI: 10.1080/02791072.2017.1333660 (opens in new tab) Full text (opens in new tab) 3-methoxyphencyclidine Arylcyclohexylamine Methoxetamine Novel psychoactive substances

Effects of the Naturalβ-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies

Journal of Psychoactive Drugs December 5, 2016 Rafael G. Dos Santos, Jaime E. C. Hallak 64 citations

Harmine is a natural β-carboline alkaloid found in several botanical species, such as the Banisteriopsis caapi vine used in the preparation of the hallucinogenic beverage ayahuasca and the seeds of Syrian rue (Peganum harmala). Preclinical studies suggest that harmine may have neuroprotective and cognitive-enhancing effects, and retrospective/observational investigations of the mental health of...

DOI: 10.1080/02791072.2016.1260189 (opens in new tab) Ayahuasca Harmine Peganum harmala Pharmacology +3

The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving

Journal of Psychoactive Drugs October 8, 2016 Noah W Sweat, Larry W. Bates, Peter S. Hendricks 48 citations

Developing methods for improving creativity is of broad interest. Classic psychedelics may enhance creativity; however, the underlying mechanisms of action are unknown. This study was designed to assess whether a relationship exists between naturalistic classic psychedelic use and heightened creative problem-solving ability and if so, whether this is mediated by lifetime mystical experience....

DOI: 10.1080/02791072.2016.1234090 (opens in new tab) Mysticism Creativity Task project management Naturalism +6

Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans

Journal of Psychoactive Drugs May 26, 2016 Amanda Amorin Nunes, Rafael G. Dos Santos, Flávia de Lima Osório et al. 92 citations

Recently, the anti-addictive potential of ayahuasca, a dimethyltryptamine(DMT)- and β-carboline-rich hallucinogenic beverage traditionally used by indigenous groups of the Northwest Amazon and currently by syncretic churches worldwide, has received increased attention. To better evaluate this topic, we performed a systematic literature review using the PubMed database to find quantitative...

The History of MDMA as an Underground Drug in the United States, 1960–1979

Journal of Psychoactive Drugs March 3, 2016 Torsten Passie, Udo Benzenhöfer 56 citations

MDMA (3,4-methylenedioxy-methylamphetamine, a.k.a. "ecstasy") was first synthesized in 1912 and resynthesized more than once for pharmaceutical reasons before it became a popular recreational drug. Partially based on previously overlooked U.S. government documentation, this article reconstructs the early history of MDMA as a recreational drug in the U.S. from 1960 to 1979. According to the...

Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report.

Journal of Psychoactive Drugs 2016 Laurie Cloutier-Gill, Evan Wood, Trevor Millar et al. 22 citations

Opioid use disorders (OUD) translate into major health, social, and economic consequences. Opioid agonist medications, which generally require long-term administration, are the mainstay pharmacological treatment of OUD. However, a large proportion of individuals with OUD either refuse or fail to respond to these therapies. Ibogaine, a naturally occurring substance found in the Tabernanthe iboga...

DOI: 10.1080/02791072.2016.1180467 (opens in new tab) Full text (opens in new tab) Methadone maintance therapy Opioid agonist treatment Opioid use disorders Ibogaine treatment +7

"Quite a Profoundly Strange Experience": An Analysis of the Experiences of Salvia divinorum Users.

Journal of Psychoactive Drugs 2016 Fiona Hutton, Bronwyn M Kivell, Otis Boyle 5 citations

Salvia divnorum (an intense hallucinogen) is currently illegal in New Zealand under the 2014 Psychoactive Substances Amendment Act. Despite this, there is a scarcity of research surrounding Salvia divinorum and its effects in a New Zealand context. To explore the experiences of Salvia divinorum users, an anonymous questionnaire was advertised through flyers placed in locations where young...

A Case of 3,4-Dimethoxyamphetamine (3,4-DMA) and 3,4-Methylenedioxymethamphetamine (MDMA) Toxicity with Possible Metabolic Interaction.

Journal of Psychoactive Drugs 2016 Michael A Darracq, Stephen L Thornton, Alicia B Minns et al. 2 citations

We present a case of "ecstasy" ingestion revealing 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-dimethoxyamphetamine (3,4-DMA) and absence of cytochrome P450 (CYP)-2D6 MDMA metabolites. A 19-year-old presented following a seizure. Initial vital signs were normal. Laboratories were normal with the exception of sodium 127 mEq/L and urine drugs of abuse screen positive for amphetamines. Twelve...

DOI: 10.1080/02791072.2016.1225324 (opens in new tab) Full text (opens in new tab) 3,4 dimethoxyamphetamine dma 3,4-methylenedioxymethamphetamine Pharmacokinetics

"Trip-Sitting" in the Black Hole: A Netnographic Study of Dissociation and Indigenous Harm Reduction.

Journal of Psychoactive Drugs 2016 Evelyn Hearne, Marie Claire Van Hout

An array of dissociative novel psychoactive substances, including "methoxetamine," "3-MeO-PCP," and "methoxphenidine," have emerged as substitutes for the illicit substance "ketamine." A netographic research methodology aimed to describe online, dissociative novel psychoactive substance users' perceptions of risk, informed knowledge around use, and indigenous harm-reduction practices as...

A Public-Health-Based Vision for the Management and Regulation of Psychedelics.

Journal of Psychoactive Drugs 2016 Mark Haden, Brian Emerson, Kenneth W. Tupper

The Health Officers Council of British Columbia has proposed post-prohibition regulatory models for currently illegal drugs based on public health principles, and this article continues this work by proposing a model for the regulation and management of psychedelics. This article outlines recent research on psychedelic substances and the key determinants of benefit and harm from their use. It...

DOI: 10.1080/02791072.2016.1202459 (opens in new tab) Full text (opens in new tab) Drug policy Drug regulation Psychedelic Psychoactive +1

Ayahuasca Tourism: Participants in Shamanic Rituals and their Personality Styles, Motivation, Benefits and Risks

Journal of Psychoactive Drugs October 20, 2015 Veronika Kavenská, Hana Šimonová 109 citations

Ayahuasca continues to attract tourists to South America, where there has been a growth in the number of centers offering hallucinogenic ayahuasca experiences. The aims of this study were to (1) discover the reasons foreigners seek this type of experience; (2) define what an ayahuasca experience entails; (3) discover subjective perceptions of ayahuasca's benefits and risks; and (4) describe...

Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey

Journal of Psychoactive Drugs October 20, 2015 Emmanuelle A. D. Schindler, Christopher Gottschalk, Marsha J. Weil et al. 104 citations

Cluster headache is one of the most debilitating pain syndromes. A significant number of patients are refractory to conventional therapies. The Clusterbusters.org medication use survey sought to characterize the effects of both conventional and alternative medications used in cluster headache. Participants were recruited from cluster headache websites and headache clinics. The final analysis...

Application of the Passionate Attachment Model to Recreational Use of MDMA/Ecstasy

Journal of Psychoactive Drugs 2015 Alan K. Davis, Harold Rosenberg 15 citations

Those who are not addicted to ecstasy, but who use it persistently over time, could be viewed as having a "passionate attachment" to a highly valued activity. To evaluate the associations of obsessive and harmonious passion with psychological and behavioral aspects of ecstasy consumption, we recruited a community sample of ecstasy users to complete a modified version of the Passion Scale...

The Association of Salvia divinorum and Psychotic Disorders: A Review of the Literature and Case Series.

Journal of Psychoactive Drugs 2015 Joseph El-Khoury, Nayiri Sahakian 15 citations

The association of substance abuse and psychotic disorders is of interest to clinicians, academics, and lawmakers. Commonly abused substances, such as cannabis, cocaine, amphetamines, and alcohol, have all been associated with substance-induced psychosis. Hallucinogens can induce desired psychedelic effects and undesirable psychomimetic reactions. These are usually transient and resolve once...